NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-04 18:36இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Dhanuka Agritech Q2 FY27 Concall: Revenue Rises 9.91% to ₹657.51 Cr, PAT Up 16.2% to ₹109.22 Cr
Dhanuka Agritech released its Q2 FY27 earnings call transcript, highlighting a 9.91% YoY increase in revenue to ₹657.51 crore and a 16.2% rise in PAT to ₹109.22 crore despite a subdued agrochemical environment. Performance was steered by strong growth in the insecticide segment, which contributed 47% of revenue, offsetting an 8% drop in herbicides caused by erratic monsoon rainfall (down 13%). Management signaled cautious optimism for the upcoming Rabi season while expecting Q3 and Q4 to remain subdued overall. The company remains committed to expanding manufacturing at Dahej by launching two active ingredient fungicide products.
உச்சம் நம்பிக்கை
என்ன மாறியதுFiling of the full analyst conference call transcript following the Q2 FY27 results announcement.
ஏன் இது முக்கியம்Demonstrates Dhanuka's ability to maintain margin resilience and outperform peers via specialized products and insecticides during adverse weather conditions and pricing pressure in generic agrochemicals.
📅 குறுகிய காலம்Performance details provide clarity on resilient gross margins; however, management's commentary points to a subdued demand backdrop for Q3 and Q4 FY27.
📈 நீண்ட காலம்Backward integration at the Dahej synthesis plant and expansion of new active ingredients (9(3) molecules) represent key structural margin drivers over the medium-to-long term.
⚠ அபாய எச்சரிக்கைகள்
Subdued industry demand and inability to fully pass through elevated raw material costs
Dahej plant operating at short-term EBITDA losses pending product additions and scale
Prevalence of spurious and duplicate products in key domestic markets
👀 கவனிக்க வேண்டியவை
Track initial Rabi season off-take in South and East zones and monitor updates on capex allocation and commercialization timelines for the two new technical products at the Dahej facility.
Dhanuka Agritech Q2 Net Profit Rises 16.23% YoY to ₹109.22 Cr; Revenue Up 9.91%
Dhanuka Agritech reported a 16.23% YoY rise in consolidated net profit to ₹109.22 crore for Q2 FY27, compared to ₹93.97 crore in Q2 FY26. Revenue from operations increased 9.91% YoY to ₹657.51 crore from ₹598.25 crore. Operating performance remained steady with EBITDA up 11.88% YoY to ₹152.97 crore, though gross margins contracted slightly to 41.18% from 42.45%. Profit growth outpaced revenue gains, driven by healthy channel inventory liquidation and steady autumn demand.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka announced Q2 FY27 earnings showing double-digit profit growth (16.23%) and ~10% revenue expansion.
ஏன் இது முக்கியம்Demonstrates operating leverage and pricing discipline despite minor gross margin compression, supporting cash flow in a seasonally key agricultural quarter.
Q2 FY27 Revenue: ₹657.51 கோடிQ2 FY27 PAT: ₹109.22 கோடிQ2 FY27 EBITDA: ₹152.97 கோடிGross Margin: 41.18%Q2 வருவாய் vs TTM வருவாய்: ~33.2%
📅 குறுகிய காலம்Earnings outperformance relative to recent muted quarterly trends may support sentiment over the coming trading sessions.
📈 நீண்ட காலம்Growth remains linked to ramp-up of backward integration at the Dahej technical plant and execution in expanding 9(3) specialty molecules.
⚠ அபாய எச்சரிக்கைகள்
Slight YoY compression in gross margin (down 127 bps to 41.18%)
Weather and seasonal dependencies impacting farm cycles
👀 கவனிக்க வேண்டியவை
Track winter crop (Rabi) sowing progress and channel inventory liquidation trends in subsequent quarters, along with margin commentary during upcoming earnings calls.
Dhanuka Q2 FY27 PAT Rises 16.2% to Rs 109.2 Cr; Dahej Plant Nears 70.8% Utilization
Dhanuka Agritech released its Q2 FY2026-27 investor presentation, reporting a 9.9% YoY growth in revenue from operations to Rs 657.51 crore and a 16.2% increase in PAT to Rs 109.22 crore. EBITDA margin improved slightly to 23.27% from 22.85% in Q2 FY26. Management announced that the Dahej technical synthesis plant is targeted to hit 70.75% capacity utilization by the end of this financial year, triggering plans for an upcoming capacity expansion. However, full-year FY27 guidance remains cautious, expecting low single-digit revenue growth and an EBITDA margin contraction of approximately 125 bps.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka reported its Q2 FY2026-27 financial performance and detailed operating metrics, including upcoming capacity expansion triggers at Dahej.
ஏன் இது முக்கியம்Demonstrates resilient quarterly earnings despite a 13% deficit in monsoon rainfall, though subdued FY27 guidance reflects ongoing industry-wide margin pressures.
📅 குறுகிய காலம்Quarterly earnings beat challenges from a weak monsoon season, but the cautious annual guidance of lower single-digit top-line growth may cap near-term valuation upside.
📈 நீண்ட காலம்Backward integration at Dahej and manufacturing scale-up of acquired Bayer fungicide brands will enhance export presence and gross margins over multi-year cycles.
⚠ அபாய எச்சரிக்கைகள்
Monsoon variability impacting agrochemical demand
Guidance indicates a full-year EBITDA margin contraction of ~125 bps
Raw material procurement cost volatility
👀 கவனிக்க வேண்டியவை
Track the execution timeline and capex announcement for the proposed Dahej facility expansion, alongside the commercialization rollout of the acquired Bayer AG molecules.
Dhanuka Agritech has received 7 demand orders totaling ₹55.53 crore from the Excise & Taxation Department, Gurugram, under the Haryana Tax on Entry of Goods into Local Areas Act, 2008. The assessment covers seven financial years spanning from FY 2008-09 to FY 2014-15, with annual demands ranging from ₹5.64 crore to ₹10.75 crore. The total demanded amount represents approximately 21% of Dhanuka's TTM net profit of ₹265 crore and ~3.3% of its net worth (₹1,682 crore). Management stated the demands are not maintainable and plans to contest them, including potentially filing a writ petition.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Excise & Taxation Department, Gurugram issued 7 demand orders aggregating to ₹55.53 crore for entry tax liabilities between FY09 and FY15.
ஏன் இது முக்கியம்While the company considers the demand non-maintainable, an adverse outcome would constitute a one-time cash outflow equal to about one-fifth of annual net profit.
Total demand orders: Rs. 55.53 CroreDemand vs TTM PAT: ~21.0%Demand vs Net worth: ~3.3%Assessment period: FY 2008-09 to FY 2014-15Date of receipt: அக்டோபர் 06, 2026
📅 குறுகிய காலம்Short-term sentiment could be mildly cautious given the cumulative liability figure, pending clarity on whether a writ petition is admitted with an interim stay.
📈 நீண்ட காலம்Limited structural impact on core agrochemical operations; entry tax disputes from that era are common legacy litigation across Haryana-based manufacturers.
⚠ அபாய எச்சரிக்கைகள்
Potential one-time cash outflow if demands are upheld by courts
Possible requirement of pre-deposit to obtain a stay on recovery
👀 கவனிக்க வேண்டியவை
Monitor legal proceedings, specifically the filing of a writ petition or stay applications in higher courts, and check subsequent quarterly filings for any provision or contingent liability disclosures.
Dhanuka Agritech Launches 2 New Crop Protection Products: Wetcit Neo and Fujita Fungicide
Dhanuka Agritech announced the domestic commercial launch of two new products on 25th September 2026. The launches include 'Wetcit Neo', an adjuvant containing avocado and blackcurrant oils, and 'Fujita', a systemic fungicide formulated with Isoprothiolane 40% EC targeting rice blast disease. Both products cater to the Indian domestic market, supporting the company's strategy of refreshing its portfolio with specialty formulations. Commercial revenue potential and margin contributions from these launches were not disclosed in the filing.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka expanded its crop protection portfolio in India with two newly launched domestic products: an adjuvant and a systemic fungicide.
ஏன் இது முக்கியம்Broadens Dhanuka's higher-value specialty product offerings and helps combat diseases in key crops like rice, supporting long-term formulation revenue.
New products launched: 2Fujita active formulation: Isoprothiolane 40% ECTTM Revenue context: Rs 1978 கோடி
📅 குறுகிய காலம்Limited direct financial impact in the immediate weeks, though positive for market sentiment regarding product pipeline execution.
📈 நீண்ட காலம்Strengthens Dhanuka's product portfolio mix towards proprietary and specialty blends, contributing incrementally to target growth and margins.
⚠ அபாய எச்சரிக்கைகள்
Adoption risk among farmers and competition from generic fungicide alternatives
Seasonal vulnerability to monsoons and disease incidence
👀 கவனிக்க வேண்டியவை
Track subsequent quarterly commentary to gauge adoption rates and revenue contribution from these new formulations, particularly Fujita's traction during the Kharif/Rabi paddy disease cycles.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Dhanuka Agritech Launches POLIN (20% SC) Fungicide in India in Tie-Up with Nippon Soda
Dhanuka Agritech has launched a new product named 'POLIN', a 20% SC fungicide developed in collaboration with Nippon Soda, Japan. The product features a novel DHODHI mode of action (FRAC 52) and targets Leaf and Neck Blast in crops. It is introduced specifically for the domestic Indian market, reinforcing Dhanuka's pipeline of specialty 9(3) molecules which generated 13.29% of FY24 revenue. Financial revenue potential and pricing were not disclosed in the filing.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka Agritech added a new proprietary-partnership fungicide, POLIN (20% SC), to its domestic crop protection portfolio.
ஏன் இது முக்கியம்Expands Dhanuka's premium fungicide offerings with an innovative Japanese active ingredient, supporting its strategy to lift margins via 9(3) specialty molecules.
Rs 200 Cr Nagpur Plant Expansion Announced as Q1 FY27 Revenue Drops 12.5%
Dhanuka Agritech reported a challenging Q1 FY27 with revenue declining 12.56% YoY to Rs 461.93 Cr, impacted by a 40% rainfall deficit in June which delayed sowing. Despite short-term headwinds, the company announced a significant new formulation plant in Nagpur with a Rs 200 Cr outlay and 23,000 MTPA capacity, expected to be operational by April 2028. The company also completed a Rs 70 Cr share buyback at Rs 1,400 per share and is launching 5 new products to drive recovery in the coming quarters.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka has committed to a new Rs 200 Cr formulation facility in Nagpur and is actively expanding its international footprint using brands acquired from Bayer.
ஏன் இது முக்கியம்The new capacity and international brand rights represent a shift toward higher-margin specialty products and global markets, reducing dependency on the volatile Indian monsoon cycle.
Nagpur Plant Outlay: Rs 200 கோடிCapex vs Net Worth: ~11.9%Q1 FY27 Revenue: Rs 461.93 கோடிNagpur Plant Capacity: 23,000 MTPABuyback Price: Rs 1,400 per share
📅 குறுகிய காலம்The stock may face pressure due to the 12.5% revenue decline and subdued Q1 margins, though the buyback at a premium provides some floor.
📈 நீண்ட காலம்Structural growth is supported by the Dahej backward integration and the upcoming Nagpur plant, alongside a focus on 9(3) patented molecules which command higher margins.
⚠ அபாய எச்சரிக்கைகள்
Climatic dependency (monsoon)
Execution risk for Nagpur plant (2028 timeline)
Pricing pressure in the generic agrochemical segment
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in Q2 and Q3 volumes as monsoon deficits narrowed to 15% by July-end, and track the execution of the Nagpur formulation plant scheduled for 2028.
Dhanuka Q1 PAT Falls 34.6% to ₹36.3 Cr; Announces ₹200 Cr Nagpur Plant Expansion
Dhanuka Agritech reported a weak Q1 FY27 with revenue declining 12.6% YoY to ₹461.93 Cr, impacted by delayed monsoons and postponed sowing. Profitability saw a sharp contraction as PAT fell 34.6% to ₹36.30 Cr and EBITDA margins dropped from 15.75% to 11.91%. To offset the expiry of incentives at its Udhampur unit, the company announced a ₹200 Cr investment for a new 23,000 MT/Annum plant in Nagpur, expected to be operational by April 2028. Management issued cautious guidance for FY27, expecting only lower single-digit revenue growth and a 200bps decline in EBITDA margins.
உச்சம் நம்பிக்கை
என்ன மாறியதுDhanuka's Q1 performance significantly lagged the previous year due to climatic factors, and the company has pivoted to a major new capex cycle in Maharashtra to replace expiring tax-incentivized capacity.
ஏன் இது முக்கியம்The ₹200 Cr capex represents approximately 11.9% of the company's net worth, signaling a major commitment to maintaining manufacturing scale despite current margin pressures and industry-wide headwinds.
Q1 PAT Growth (YoY): -34.59%Nagpur Capex Outlay: ₹200 கோடிCapex vs Net Worth: ~11.9%Proposed Plant Capacity: 23,000 MT/AnnumFY27 Margin Guidance Change: -200bpsBuyback Price: ₹1,400
📅 குறுகிய காலம்The stock may face pressure in the near term due to the sharp earnings miss and the management's cautious outlook on full-year margins.
📈 நீண்ட காலம்Structural growth depends on the successful ramp-up of the Dahej technical synthesis facility and the timely completion of the Nagpur plant by 2028 to restore margin profiles.
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in demand during Q2 following the monsoon onset and track the execution timeline of the Nagpur plant, which is critical for long-term tax efficiency. The impact of 5 upcoming product launches on H2 margins will be a key performance indicator.
Dhanuka Agritech Completes Extinguishment of 5 Lakh Equity Shares Post-Buyback
Dhanuka Agritech has successfully completed the extinguishment of 5,00,000 equity shares following its recent buyback program. This process has reduced the company's total paid-up equity share capital from 4,50,78,324 shares to 4,45,78,324 shares. As a result of the reduced share base, the promoter group's holding has marginally increased from 69.71% to 69.81%. This reduction in equity is expected to have a positive impact on the company's Earnings Per Share (EPS) and Return on Equity (ROE).
முக்கிய அம்சங்கள்
Extinguished 5,00,000 fully paid-up equity shares with a face value of Rs. 2 eachTotal issued and paid-up equity capital reduced to 4,45,78,324 shares (Rs. 8,91,56,648)Promoter shareholding increased from 69.71% to 69.81% post-extinguishmentPublic shareholding adjusted to 30.19% of the total post-buyback capital
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive capital allocation move that enhances shareholder value through equity base reduction. No specific action is required as this is the formal conclusion of the previously announced buyback.
Dhanuka Agritech Announces ₹70 Crore Buyback at ₹1,400 Per Share; Offer Opens June 4
Dhanuka Agritech Limited has finalized the Letter of Offer for its buyback of 5,00,000 equity shares at a price of ₹1,400 per share. The total buyback size is ₹70 crore, representing 4.20% of the company's paid-up share capital and free reserves. The offer will be conducted via the tender route, with the record date having passed on May 29, 2026. Small shareholders have been allocated a significantly higher entitlement ratio of 1 share for every 15 shares held.
முக்கிய அம்சங்கள்
Buyback price of ₹1,400 per share represents a premium over the current market price.Total buyback size is ₹70 crore for 5,00,000 shares, which is 1.11% of total equity.Tender offer window is scheduled from June 4, 2026, to June 10, 2026.Small shareholder entitlement ratio is approximately 7.13% (1:15), while the general category is 0.96% (5:518).The buyback is funded through internal accruals and represents 4.20% of the company's net worth.
👀 கவனிக்க வேண்டியவை
Eligible shareholders as of the May 29 record date should consider tendering their shares during the June 4-10 window to capitalize on the ₹1,400 exit price. Small shareholders, in particular, should note their higher entitlement ratio which increases the likelihood of successful acceptance.
Dhanuka Agritech Q4 FY26 PAT Jumps 29.5% to ₹97.77 Cr; Announces ₹70 Cr Buyback
Dhanuka Agritech reported a resilient Q4 FY26 with revenue growing 9% YoY to ₹483.34 crores, despite challenging climatic conditions and global volatility. Net profit surged nearly 30% to ₹97.77 crores, significantly bolstered by GST refunds from its Udhampur unit and improved operational efficiencies. The company announced a ₹70 crore share buyback at ₹1,400 per share and a 100% dividend of ₹2 per share. Management is actively pursuing backward integration at its Dahej plant and expanding the international distribution of products acquired from Bayer.
முக்கிய அம்சங்கள்
Revenue from operations grew 9.3% YoY to ₹483.34 crores in Q4 FY26.PAT increased by 29.5% to ₹97.77 crores, aided by GST refunds and disciplined cost management.Board approved a buyback of up to 5 lakh shares at ₹1,400 per share, totaling ₹70 crores.Recommended a 100% dividend of ₹2 per equity share for the financial year.Insecticides and Herbicides remained the largest product categories, contributing 41% and 31% to turnover respectively.
👀 கவனிக்க வேண்டியவை
The buyback at a premium and consistent dividend payouts reflect strong cash flow and management confidence. Investors should monitor the successful scaling of the Dahej plant and international registrations for long-term value creation.
Dhanuka Agritech Q4 Net Profit Jumps 29.5% to Rs 97.77 Cr; Announces Rs 70 Cr Buyback
Dhanuka Agritech reported a robust Q4 FY26 with net profit rising 29.50% YoY to Rs 97.77 crore, driven by favorable Rabi season conditions. Revenue grew 9.35% YoY to Rs 483.34 crore, while EBITDA saw a 13.79% increase. The company announced a share buyback of 5 lakh shares at Rs 1,400 per share and a final dividend of Rs 2 per share. Furthermore, the board has authorized international expansion into Brazil and Europe to strengthen its global footprint.
முக்கிய அம்சங்கள்
Net Profit for Q4 FY26 increased by 29.50% YoY to Rs 97.77 crore.Revenue from operations rose 9.35% YoY to Rs 483.34 crore in the March quarter.Approved a share buyback of up to 5,00,000 equity shares at Rs 1,400 per share, totaling Rs 70 crore.Recommended a final dividend of 100% (Rs 2 per share) for the financial year 2025-26.Strategic expansion planned through new wholly-owned subsidiaries in Brazil and European countries.
👀 கவனிக்க வேண்டியவை
The strong earnings growth combined with a buyback at a premium and international expansion plans signal high management confidence. Investors may consider holding for long-term gains as the company scales its global presence.
Dhanuka Agritech Approves ₹70 Cr Buyback at ₹1,400/Share, ₹2 Dividend & Global Expansion
Dhanuka Agritech's board has approved a share buyback of up to 5,00,000 shares at ₹1,400 per share, representing a total outlay of ₹70 crore via the tender route. The company also declared a final dividend of ₹2 per share (100%) for FY26 with a record date of July 17, 2026. Furthermore, the board approved setting up wholly-owned subsidiaries in Brazil and Europe with an initial investment of ₹1 crore each to facilitate global brand registrations. New employee incentive schemes (ESOP and SARs) were also introduced to align management interests.
முக்கிய அம்சங்கள்
Buyback of 5 lakh shares (1.11% of capital) at ₹1,400 per share via tender offer route.Total buyback size capped at ₹70 crore with a record date fixed for May 29, 2026.Final dividend of ₹2 per share (100% of face value) recommended for the financial year 2025-26.Expansion into Brazil and Europe via new subsidiaries to manage brand registrations and international growth.Introduction of ESOP 2026 and SARs 2026 plans covering approximately 0.39% of total equity capital.
👀 கவனிக்க வேண்டியவை
Investors should note the May 29 record date to be eligible for the tender-route buyback which is priced at a premium. The expansion into Brazil and Europe signals a long-term strategy to scale the export and brand portfolio.
Dhanuka Agritech reported a challenging Q3 FY26 with revenue declining 7.9% YoY to ₹409.92 crores and PAT falling 27.3% to ₹40 crores. The performance was hampered by weak demand in South and West India, lower crop prices, and regulatory hurdles in the biologicals segment which caused a ₹49 crore impact over nine months. However, management expressed optimism for Q4, citing a strong start in January and the commercialization of new products from the Dahej plant. The company maintains a healthy cash position of over ₹250 crores and expects biostimulant approvals by the end of the current quarter.
முக்கிய அம்சங்கள்
Revenue from operations decreased to ₹409.92 crores in Q3 FY26 from ₹445.27 crores in Q3 FY25EBITDA fell significantly to ₹58.66 crores compared to ₹75.56 crores in the previous year's quarterRegulatory changes in biostimulants led to a significant sales impact of ₹49 crores during the first nine months of FY26Management targets EBITDA-positive operations for the Dahej plant in FY27 with 80% capacity utilizationCash and liquid investments remain strong at over ₹250 crores as of December 2025
👀 கவனிக்க வேண்டியவை
Investors should monitor the recovery in Q4 and the successful re-launch of biostimulant products in Q1 FY27. While Q3 was weak, the management's commentary on January performance and Dahej plant scaling suggests a potential turnaround.
Dhanuka Agritech Q3 FY26 PAT Drops 27% YoY to ₹40 Cr Amid Weak Agrochemical Demand
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.94% YoY to ₹409.92 Crores. Profitability took a significant hit as PAT fell 27.33% to ₹40 Crores, and EBITDA margins contracted by 266 bps to 14.31%. The company attributed the decline to stressed demand drivers, including adverse weather and low crop prices, particularly in South and West India. Management has issued a cautious guidance for the full year FY26, expecting flat revenue and a 100 bps decline in EBITDA margins.
முக்கிய அம்சங்கள்
Revenue from operations decreased 7.94% YoY to ₹409.92 Crores in Q3 FY26.EBITDA declined by 22.37% YoY to ₹58.66 Crores, with margins contracting to 14.31%.Net Profit (PAT) dropped 27.33% YoY to ₹40.00 Crores from ₹55.04 Crores in Q3 FY25.Management expects flat revenue for FY26 and a margin compression of approximately 100 bps.Innovation Turnover Index (new molecules) contributed 16.32% to total revenue for 9M FY26.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces headwinds from weak rural demand and margin pressure. The focus should be on the Dahej plant's progress, which is targeted to become EBITDA positive in FY27.
Dhanuka Agritech Q3 Net Profit Drops 27% to ₹40 Crore; New Independent Director Appointed
Dhanuka Agritech reported a weak set of numbers for Q3 FY26, with revenue from operations declining 7.9% year-on-year to ₹409.92 crore. Net profit for the quarter fell significantly by 27.3% to ₹40 crore, down from ₹55.04 crore in the same period last year. The company attributed performance variations to seasonal factors like monsoon and pest infestation patterns. Additionally, the board has appointed Mr. Sanjiv Goel as an Independent Director for a five-year term starting February 2026, following the cessation of Mr. Sachin Kumar Bhartiya's term.
முக்கிய அம்சங்கள்
Revenue from operations decreased to ₹409.92 crore in Q3 FY26 compared to ₹445.27 crore in Q3 FY25.Net profit for the quarter declined 27.3% YoY to ₹40 crore, with EPS dropping to ₹8.87 from ₹12.25.Nine-month PAT for FY26 stands at ₹189.46 crore, a 14.4% decrease from ₹221.46 crore in the previous year.Recognized a ₹2.5 crore incremental impact in employee benefits due to the new Code on Wages compliance.Mr. Sanjiv Goel appointed as Independent Director for 5 years; Mr. Sachin Kumar Bhartiya to exit on Feb 8, 2026.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the company faces margin pressure and declining year-on-year growth. Monitor the upcoming monsoon outlook and management's strategy to counter seasonal volatility in the agro-chemical segment.
Dhanuka Agritech appoints Mahesh Sonawane as General Manager- Quality
Dhanuka Agritech Limited announced the appointment of Mr. Mahesh Parshuram Sonawane as Senior Management Personnel, specifically as General Manager- Quality, effective December 15th, 2025. Mr. Sonawane brings over 22 years of experience in Quality Management. He previously held senior leadership positions at Atul Limited, Syngenta India Limited, and Bayer CropScience Ltd. This appointment strengthens the company's quality assurance capabilities.
முக்கிய அம்சங்கள்
Mr. Mahesh Parshuram Sonawane appointed as General Manager- Quality w.e.f. 15th December 2025Mr. Sonawane has over 22 years of experience in Quality ManagementMr. Sonawane holds a Master of Science (M.Sc.) degree in ChemistryMr. Sonawane previously worked at Atul Limited, Syngenta India Limited, and Bayer CropScience Ltd.
👀 கவனிக்க வேண்டியவை
Investors should monitor how this appointment impacts Dhanuka Agritech's product quality and operational efficiency. No immediate action is required, but keep an eye on future reports regarding quality improvements.
Dhanuka Agritech Q2 FY26 Net Profit Declines 20% YoY to ₹93.97 Crore
Dhanuka Agritech reported a weak set of numbers for the quarter ended September 30, 2025. Revenue from operations decreased by 8.5% YoY to ₹598.25 crore, while Net Profit saw a significant drop of 20% to ₹93.97 crore compared to the same period last year. For the first half of FY26, the company's net profit stood at ₹149.47 crore, down from ₹166.41 crore in H1 FY25. The management attributed performance variations to seasonal factors like monsoon and pest infestation patterns.
முக்கிய அம்சங்கள்
Revenue from operations fell 8.5% YoY to ₹598.25 crore in Q2 FY26.Net Profit for the quarter declined 20% YoY to ₹93.97 crore from ₹117.52 crore.Earnings Per Share (EPS) dropped to ₹20.85 in Q2 FY26 from ₹25.83 in Q2 FY25.H1 FY26 total income stood at ₹1,140.90 crore, a slight decrease from ₹1,165.79 crore in H1 FY25.Inventory levels increased significantly to ₹478.21 crore as of Sept 30, 2025, compared to ₹398.74 crore in March 2025.
👀 கவனிக்க வேண்டியவை
The decline in both top-line and bottom-line performance indicates a challenging environment for the agrochemical major. Investors should exercise caution and monitor the company's ability to manage rising inventory and recovery in demand during the upcoming rabi season.
Dhanuka Agritech Receives Rs 121.32 Crore GST Demand Order
Dhanuka Agritech has received a GST demand order from the Central Goods & Service Tax authority in Ahmedabad totaling Rs 121.32 crore. The demand consists of a tax component of Rs 60.66 crore and a penalty of Rs 60.66 crore. The dispute centers on the classification of products as fertilizers (5% GST) versus plant growth regulators (18% GST). The company believes the demand is not maintainable and is preparing to file an appeal, stating there is no immediate impact on operations.
முக்கிய அம்சங்கள்
Total demand of Rs 121.32 crore includes Rs 60.66 crore tax and Rs 60.66 crore penaltyDispute involves classification of products under HSN 3101 (5% GST) vs HSN 3808 (18% GST)The order was received from the office of the Central Goods & Service Tax, Ahmedabad on December 9, 2025Company is evaluating legal options and intends to file an appeal against the adjudicating authority
👀 கவனிக்க வேண்டியவை
Investors should monitor the legal proceedings as the demand amount is significant; however, the company's intent to appeal suggests no immediate cash outflow.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
